PTC Therapeutics, Inc. (PTCT) Financials

$43.92

north_east
$0.84 (1.95%)
Day's range
$42.18
Day's range
$44.54
Profit Margin
Revenue
Earnings
$1B$1B$500M$500M$0$0-$500M-$500M-$1B-$1BEarning20172017201820182019201920202020202120212022202220232023-40%-40%-60%-60%-80%-80%-100%-100%-120%-120%Profit Margin

PTCT Income statement / Annual

Last year (2023), PTC Therapeutics, Inc.'s total revenue was $937.82 M, an increase of 34.20% from the previous year. In 2023, PTC Therapeutics, Inc.'s net income was -$626.60 M. See PTC Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $937.82 M $698.80 M $538.59 M $380.77 M $306.98 M $264.73 M $194.39 M $82.71 M $36.77 M $22.96 M
Cost of Revenue $65.49 M $44.68 M $32.33 M $18.94 M $12.14 M $12.67 M $4.58 M $117.63 M $121.82 M $79.84 M
Gross Profit $872.34 M $654.12 M $506.27 M $361.82 M $294.85 M $252.06 M $189.82 M -$34.93 M -$85.05 M -$56.88 M
Gross Profit Ratio 0.93 0.94 0.94 0.95 0.96 0.95 0.98 -0.42 -2.31 -2.48
Research and Development Expenses $666.56 M $651.50 M $540.68 M $477.64 M $257.45 M $171.98 M $117.46 M $117.63 M $121.82 M $79.84 M
General & Administrative Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $153.55 M $121.27 M $97.13 M $82.08 M $44.82 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $332.54 M $326.00 M $285.77 M $245.16 M $202.54 M $153.55 M $121.27 M $97.13 M $82.08 M $44.82 M
Other Expenses $0.00 $116.55 M $54.75 M $36.89 M $27.65 M $129,000.00 -$1.28 M -$1.21 M -$465,000.00 -$213,000.00
Operating Expenses $1.31 B $1.09 B $881.21 M $759.70 M $487.64 M $348.41 M $254.11 M $214.76 M $203.90 M $122.38 M
Cost And Expenses $1.29 B $1.14 B $913.54 M $778.64 M $499.78 M $361.08 M $258.68 M $214.76 M $203.90 M $122.38 M
Interest Income $0.00 $90.87 M $86.02 M $56.35 M $12.49 M $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $129.18 M $90.87 M $86.02 M $56.35 M $12.49 M $12.55 M $12.09 M $8.28 M $2.37 M $1.18 M
Depreciation & Amortization $236.59 M $128.84 M $71.52 M $49.58 M $36.06 M $26.09 M $17.68 M $3.29 M $2.88 M $2.24 M
EBITDA -$330.34 M -$367.78 M -$374.44 M -$297.00 M -$191.38 M -$89.47 M -$46.61 M -$128.77 M -$164.25 M -$97.18 M
EBITDA Ratio -0.35 -0.53 -0.7 -0.6 -0.38 -0.2 -0.25 -1.6 -4.55 -4.33
Operating Income Ratio -0.37 -0.63 -0.7 -1.04 -0.63 -0.44 -0.33 -1.6 -4.55 -4.33
Total Other Income/Expenses Net -$346.71 M -$147.56 M -$143.40 M -$59.36 M -$47.13 M -$12.43 M -$13.37 M -$9.48 M -$2.83 M $967,000.00
Income Before Tax -$696.11 M -$587.49 M -$518.34 M -$402.93 M -$239.93 M -$128.11 M -$77.67 M -$141.54 M -$169.96 M -$98.45 M
Income Before Tax Ratio -0.74 -0.84 -0.96 -1.06 -0.78 -0.48 -0.4 -1.71 -4.62 -4.29
Income Tax Expense -$69.51 M -$28.47 M $5.56 M $35.23 M $11.65 M -$29,000.00 $1.34 M $569,000.00 $485,000.00 -$4.69 M
Net Income -$626.60 M -$559.02 M -$523.90 M -$438.16 M -$251.58 M -$128.08 M -$79.00 M -$142.11 M -$170.45 M -$93.75 M
Net Income Ratio -0.67 -0.8 -0.97 -1.15 -0.82 -0.48 -0.41 -1.72 -4.64 -4.08
EPS -8.37 -7.79 -7.43 -6.64 -4.27 -2.75 -2.02 -4.17 -5.07 -2.97
EPS Diluted -8.37 -7.79 -7.43 -6.64 -4.27 -2.75 -2.02 -4.17 -5.07 -2.97
Weighted Average Shares Out $74.84 M $71.73 M $70.47 M $66.03 M $58.86 M $46.58 M $39.11 M $34.04 M $33.62 M $31.57 M
Weighted Average Shares Out Diluted $74.84 M $71.73 M $70.47 M $66.03 M $58.86 M $46.58 M $39.18 M $34.04 M $33.63 M $31.57 M
Link